Long-term cardiac ischemia leading to coronary artery bypass grafting in a tetraplegic patient

Archives of Physical Medicine and Rehabilitation

Volumn 79, Issue 9, 1998, Pages 1129-1132

  Groah, Suzanne L ^a   Menter, Robert R ^a  

^a CRAIG HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CAROTID ENDARTERECTOMY; CASE REPORT; CORONARY ARTERY BYPASS GRAFT; HEART MUSCLE ISCHEMIA; HUMAN; HYPERCHOLESTEROLEMIA; MALE; PHYSICAL MEDICINE; QUADRIPLEGIA; RISK FACTOR; SURVIVAL TIME;

EID: 0031703786     PISSN: 00039993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-9993(98)90183-6     Document Type: Article

References (31)

1. American Heart Association Web Page. Http://www.amhrt.org/ 1997/stats/CardDise.html.
2. National Center for Health Statistics. Advance report of final mortality statistics, 1990. Mon Vital Stat Rep 1993;41(7 Suppl): 1-52.
3. Nygard O, Vollset SE, Refsum H, Stensvold I, Tverdal A, Nordrehaug JE, et al. Total plasma homocysteine and cardiovascular risk profile. The Hordaland homocysteine study. JAMA 1995; 274:1526-33.
4. Verhoef P, Stampfer MJ. Prospective studies of homocysteine and cardiovascular disease. Nutr Rev 1995;53:283-8.
5. Alfthan G, Aro A, Gey KF. Plasma homocysteine and cardiovascular disease mortality [letter]. Lancet 1997;349:397.
6. Gillum RF. Trends in acute myocardial infarction and coronary heart disease death in the United States. J Am Coll Cardiol 1994;23:1273-7.
7. Sytkowski PA, D'Agostino RB, Kannel WB. Sex and time trends in cardiovascular disease incidence and mortality: the Framingham Heart Study, 1950-1989. Am J Epidemiol 1996;143:338-50.
8. Hunink MG, Goldman L, Tosteson AN, Mittleman MA, Goldman PA, Williams LW, et al. The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatment. JAMA 1997;277:535-42.
9. Krum H, Howes LG, Brown DJ, Ungar G, Moore P, McNeil JJ, et al. Risk factors for cardiovascular disease in chronic spinal cord injury patients. Paraplegia 1992;30:381-8.
10. Yekutiel M, Brooks ME, Ohry A, Yarom J, Carel R. The prevalence of hypertension, ischaemic heart disease and diabetes in traumatic spinal cord injured patients and amputees. Paraplegia 1989;27:58-62.
11. Cardus D, Ribas-Cardus F, McTaggart WG. Coronary risk in spinal cord injury: assessment following a multivariate approach. Arch Phys Med Rehabil 1992;73:930-3.
12. Nakajima A, Honda S, Yoshimura S, Ono Y, Kawamura J, Moriai N. The disease pattern and causes of death of spinal cord injured patients in Japan. Paraplegia 1989;27:163-71.
13. Whiteneck GG, Charlifue SW, Frankel HL, Fraser MH, Gardner BP, Gerhart KA, et al. Mortality, morbidity, and psychosocial outcomes of persons spinal cord injured more than 20 years ago. Paraplegia 1992;30:617-30.
14. DeVivo MJ, Fine PR, Maetz HM, Stover SL. Prevalence of spinal cord injury: a reestimation employing life table techniques. Arch Neurol 1980;37:707-8.
15. Whiteneck GG, Charlifue SW, Gerhart KA, Lammertse DP, Manley S, Menter RR, et al, editors. Aging with spinal cord injury. New York: Demos; 1993.
16. Geisler WO, Jousse AT, Wynne-Jones M, Breithaupt D. Survival in traumatic spinal cord injury. Paraplegia 1983;21:364-73.
17. DeVivo MJ, Stover SL. Long-term survival and causes of death. In: Stover SL, DeLisa JA, Whiteneck GG, editors. Spinal cord injury: clinical outcomes for the model systems. Gaithersburg (MD): Aspen; 1995. p. 289-316.
18. Bauman WA, Spungen AM, Raza M, Rothstein J, Zhang R, Zhang V. Coronary artery disease: metabolic risk factors and latent disease in individuals with paraplegia. Mt Sinai J Med 1992;59: 163-8.
19. Cardus D, Ribas-Cardus F, MacTaggart WG. Lipid profiles in spinal cord injury. Paraplegia 1992;30:775-82.
20. Bauman WA, Spungen EM, Zhong YG, Rothstein JL, Petry C, Gordon SK. Depressed serum high density lipoprotein cholesterol levels in veterans with spinal cord injury. Paraplegia 1992;30:697-703.
21. Shetty KP, Sutton CH, Rudman IW, Rudman D. Lipid and lipoprotein abnormalities in young quadriplegic men. Am J Med Sci 1992;303:213-6.
22. Brenis G, Dearwater S, Shapera R, LaPorta RE, Collins E. High density lipoprotein cholesterol concentrations in physically active and sedentary spinal cord injured patients. Arch Phys Med Rehabil 1986;67:445-50.
23. Imai K, Kadowaki T, Aizawa Y, Fukutomi K. Morbidity rates of complications in persons with spinal cord injury according to the site of injury and with special reference to hypertension. Paraplegia 1994;30:246-52.
24. Bauman WA, Spungen AM. Disorders of carbohydrate and lipid metabolism in veterans with paraplegia or quadriplegia: a model of premature aging. Metabolism 1994;43:749-56.
25. Duckworth WC, Jallepalli P, Solomon SS. Glucose intolerance in spinal cord injury. Arch Phys Med Rehabil 1983;64:107-10.
26. Duckworth WC, Solomon SS, Jallepalli P, Heckemeyer C, Finnern J, Powers A. Glucose intolerance due to insulin resistance in patients with spinal cord injuries. Diabetes 1980;29:906-10.
27. Krum H, Howes LG, Brown DJ, Louis WJ. Blood pressure variability in tetraplegic patients with autonomic hyperreflexia. Paraplegia 1989;27:284-8.
28. Mancia G, Parati G, Albini F, Villani A. Circadian blood pressure variations and their impact on disease. J Cardiovasc Pharmacol 1988;12 Suppl 7:S11-S17.
29. Walker WC, Khokhar MS. Silent cardiac ischemia in cervical spinal cord injury: case study. Arch Phys Med Rehabil 1992;73: 91-4.
30. Bauman WA, Raza M, Spungen AM, Machac J. Cardiac stress testing with thallium-201 imaging reveals silent ischemia in individuals with paraplegia. Arch Phys Med Rehabil 1994;75: 946-50.
31. Bauman WA, Raza M, Chayes Z, Machac J. Tomographic thallium-201 myocardial perfusion imaging after intravenous dipyridamole in asymptomatic subjects with quadriplegia. Arch Phys Med Rehabil 1993;74:740-4.